Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Insight into the mechanism of action behind antitumor activity of auraptene

March 30, 2004

Use of CXCR5 receptor as target for diagnosis and treatment of cancer, cardiovascular diseases, etc.

March 30, 2004

GlaxoSmithKline patent describes thiophene compounds as polo-like kinase 1 inhibitors

March 30, 2004

Clinical experience with Tumor Necrosis Therapy shared

March 30, 2004

Anastrozole improves the outcome of breast cancer surgery

March 30, 2004

Benefits reported for exemestane as first-line treatment for advanced breast cancer

March 30, 2004

Antitumor activity of JNJ-7706621, an orally available CDK inhibitor, demonstrated in vivo

March 29, 2004

Novel retinoid-related ligand presented by Allergan at AACR meeting

March 29, 2004

European CPMP recommends approval of Erbitux in colorectal cancer

March 29, 2004

Aventis submits new U.S. and E.U. regulatory submissions for Taxotere

March 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...